TY  - JOUR
AU  - Banerjee, Sreemoti
AU  - Southgate, Jennifer
PY  - 2019
TI  - Bladder organoids: a step towards personalised cancer therapy?
JF  - Translational Andrology and Urology; Vol 8, Supplement 3 (July 16, 2019): Translational Andrology and Urology
Y2  - 2019
KW  - 
N2  - Urothelial bladder cancer (UBC) is complicated by its underlying genetic diversity that renders prognosis and treatment a challenge and imposes a significant health and economic burden. Although the non-muscle invasive form of bladder cancer (NMIBC) is responsive to treatment, a significant proportion of tumors recur and patients require lifelong monitoring to identify cancers that become muscle-invasive. Most patients with muscle-invasive bladder cancer (MIBC) present late and show poor response to therapy, with attendant poor survival. This underpins the clinical need for progress in bladder cancer research and translation.
UR  - https://tau.amegroups.org/article/view/26358